Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | -368.39% | $ -56.79M | $ 15.42M |
3/31/2025 | -1248.02% | $ -79.91M | $ 6.4M |
12/31/2024 | -1194.2% | $ -73.69M | $ 6.17M |
9/30/2024 | -1218.79% | $ -82.17M | $ 6.74M |
6/30/2024 | -819.28% | $ -82.43M | $ 10.06M |
3/31/2024 | -616.64% | $ -80.08M | $ 12.99M |
12/31/2023 | -430.15% | $ -78.03M | $ 18.14M |
9/30/2023 | -352.8% | $ -78.47M | $ 22.24M |
6/30/2023 | -317.44% | $ -74.71M | $ 23.54M |
3/31/2023 | -210.08% | $ -69.59M | $ 33.13M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for ARBUTUS BIOPHARMA CORP is calculated as follows: Op. Inc. [ $ -54.24M ] / Revenues [ $ 6.15M ]
(=) Operating % [ -882.59% ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.27K |
---|---|
min | -71.54% |
max | 83.49% |
average | 9.05% |
median | 8.75% |
std | 23.74% |